Low-dose Dexamethasone Prolongs Analgesia for Brachial Plexus Block
Researchers at University of Pennsylvania’s Perelman School of Medicine found that the addition of a low dose (1-2 mg) of dexamethasone to 0.25% bupivacaine for brachial plexus nerve block prolonged the duration of analgesia and motor blockade to a similar extent as a higher dose (4 mg).
The randomized double-blind study examined the analgesic effect of 3 doses of dexamethasone in combination with low-concentration local anesthetics to determine the lowest effective dose to use an adjuvant in supraclavicular brachial plexus block.
Eighty-nine patients scheduled for shoulder arthroscopy received a single-shot supraclavicular brachial plexus nerve block with 30 mL of 0.25% bupivacaine. In addition to the bupivacaine, patients were randomized to receive:
- No dexamethasone (control group; n=23)
- 1-mg dose of preservative-free dexamethasone (n=20)
- 2-mg dose of preservative-free dexamethasone (n=22)
- 4-mg dose of preservative-free dexamethasone (n=24
Duration of analgesia and motor block were measured.
The median duration analgesia without dexamethasone was 12.1 hours. The addition of 1-, 2-, or 4-mg dexamethasone significantly prolonged the analgesia duration to 22.3, 23.3, and 21.2 hours, respectively (P=0.0105). The duration of motor nerve block was also extended with dexamethasone in a similar trend (P=0.0247).
There was 1 episode of clinically significant paresthesia, which resolved on POD3, with no other complications noted in the study.
Source
Liu J, Richman KA, Grodofsky SR, et al. Is there a dose response of dexamethasone as adjuvant for supraclavicular brachial plexus nerve block? A prospective randomized double-blinded clinical stu